What Is Epitalon?

Anisimov et al. (Biogerontology): Extends lifespan in multiple animal models by 10-15% via telomerase activation and melatonin regulation.

Khavinson et al. demonstrate Epitalon activates telomerase catalytic subunit (hTERT) expression in human fetal fibroblasts, extending replicative lifespan by 10 population doublings.

Comprehensive 25-year review of Epitalon's antioxidant, neuroprotective, antimutagenic, and anti-cancer properties across in vitro, in vivo, and in silico models.

Korkushko et al.: Epithalamin administration normalizes melatonin production and circadian rhythm in elderly patients, improving sleep and immune function.

Therapeutic peptides offer mechanistically diverse approaches to targeting fundamental hallmarks of aging, a 2026 review demonstrated. While FDA-approved agents show clinical potential, investigational peptides require rigorous validation through well-designed trials to establish long-term safety and efficacy.

Therapeutic peptides, including BPC-157 and TB-500, were found to modulate molecular signaling networks influencing tissue regeneration and inflammation resolution in a 2026 review. The research highlighted their mechanistic potential for orthopaedic applications, noting a current lack of clinical trials.

Epitalon demonstrated dose-dependent telomere length extension in normal human cells through hTERT and telomerase upregulation in a 2025 in-vitro study. Researchers also found that the peptide increased telomere length in cancer cell lines primarily via Alternative Lengthening of Telomeres activation.

The tetrapeptide Epitalon restored delayed wound healing in high glucose-injured human retinal cells by inhibiting epithelial-mesenchymal transition and fibrosis, a 2025 in vitro study demonstrated. Researchers found that the peptide also reduced intracellular reactive oxygen species and restored antioxidant gene expression.

A 2025 review found that the tetrapeptide Epitalon demonstrates geroprotective and neuroendocrine properties through antioxidant and neuroprotective mechanisms. Researchers highlighted its ability to influence melatonin synthesis, modulate interleukin-2 levels, and enhance telomerase activity in preclinical models.

A 2025 preclinical study demonstrated that Epitalon activates telomerase, significantly improving bovine oocyte maturation rates and post-thawed embryo development. The peptide enhanced the overall quality of in vitro mature oocytes and blastocysts by improving mitochondrial health and reducing reactive oxygen species.

A study published in Voprosy onkologii investigating the effects and mechanisms.

A study published in Neuro endocrinology letters investigating the effects and mechanisms.

A study published in Cancer letters investigating the effects and mechanisms.

A study published in Drug testing and analysis investigating the effects and mechanisms.

A study published in International journal of cancer investigating the effects and mechanisms.

A study published in Neuro endocrinology letters investigating the effects and mechanisms.

A study published in Advances in gerontology = Uspekhi gerontologii investigating the effects and mechanisms.

A study published in Biogerontology investigating the effects and mechanisms.

A study published in Neuroscience and behavioral physiology investigating the effects and mechanisms.

A study published in Voprosy onkologii investigating the effects and mechanisms.

A 2024 review found that the AEDG peptide and pineal polypeptides influenced human circadian rhythms and increased melatonin secretion in older adults. The researchers demonstrated these effects occurred by regulating circadian gene expression and reducing apoptosis-promoting proteins like p16 and p53.

In a 2023 in-vitro study, researchers found that short peptide bioregulators, including Epitalon and Livagen, induced selective decondensation of chromatin and activated ribosomal genes in cultured lymphocytes from older adults. This demonstrated the peptides' ability to selectively remodel facultative heterochromatin.

A 2022 in vitro study demonstrated that Epitalon delayed the aging process of mouse oocytes by reducing reactive oxygen species and modulating mitochondrial activity. The peptide significantly decreased spindle defects and apoptosis, protecting against post-ovulatory cellular damage.

A 2022 in vitro study found that five Khavinson peptides, including Epitalon and Vilon, modulated proliferative patterns and inhibited the expression of pro-inflammatory cytokines TNF and IL-6 in human monocytic cells. Furthermore, the peptides reduced monocyte adhesion to activated endothelial cells.

In a 2020 in vitro study, researchers demonstrated that AEDG and KE peptides increased mitochondrial staining and decreased L7A ribosomal protein expression in senescent human pineal and thymic cells. These findings suggest tissue-specific normalization of mitochondrial and ribosomal functions.

A 2020 study found that the AEDG peptide increased melatonin metabolite excretion by 1.7 times in middle-aged individuals. The research also demonstrated that the peptide normalized the expression of specific circadian rhythm genes in human leukocytes and lymphocytes.

A 2020 study demonstrated that AEDG peptide increased the expression and synthesis of neurogenic differentiation markers in human stem cells. Researchers found this epigenetic regulation likely occurs through the peptide binding to specific histones.

In a 2020 in vitro study, researchers found that AEDG and KED peptides significantly decreased the expression of senescence markers p16 and p21 in human oral stem cells. This demonstrated the peptides' ability to maintain stem cell morphology and delay cellular aging during long-term cultivation.

A 2017 in-vitro study demonstrated that the short peptides epitalon, bronchogen, and vilon significantly stimulated growth and modulated the expression of genes responsible for tissue formation and cell differentiation in tobacco plant cultures.

A 2015 study in rats demonstrated that administering epithalon and melatonin restored the age-related dynamics of pepsin activity in the gastric mucosa when exposed to constant lighting. The peptides had little effect on total proteolytic activity in the stomach and pancreas.